Cargando…

Telemedicine Mediated Service Delivery for Substance Use Disorders

Telemedicine in addiction service delivery- Dr. D Basu For around last two decades, telepsychiatry has been practiced in India to reach the unreached population with variable degree of success. COVID-19 pandemic limited healthcare access due to travel and face to face consultation restrictions. It w...

Descripción completa

Detalles Bibliográficos
Autor principal: Basu, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129338/
http://dx.doi.org/10.4103/0019-5545.341811
_version_ 1784712729270943744
author Basu, D
author_facet Basu, D
author_sort Basu, D
collection PubMed
description Telemedicine in addiction service delivery- Dr. D Basu For around last two decades, telepsychiatry has been practiced in India to reach the unreached population with variable degree of success. COVID-19 pandemic limited healthcare access due to travel and face to face consultation restrictions. It warranted an urgent and widespread expansion of telepsychiatry practice, and application of the same in management of patients using substance. In spite of the advantage of increased access, there are some inherent limitations in the form of inability to perform detailed physical examination and restriction of medication prescriptions. Dr. Basu will discuss the opportunities and challenges in telemedicine-based service delivery for substance use disorders. Telemedicine and Opioid substitution treatment (OST)- Dr. A. Ghosh Opioid substitution treatment (OST) was significantly affected during pandemic, as there was a strict requirement of face-to-face consultation. Only United States shifted the buprenorphine-naloxone assisted OST induction through teleconsultation. Many other countries including India has allowed preliminary assessment for OST through teleconsultation, but induction and dispensing were essentially through in person consultation. The dispensing of OST has been mechanized in some other countries. Dr. Ghosh will review the adaptations and challenges in OST delivery during the pandemic. Telemedicine mediated service delivery in the Drug Deaddiction & Treatment Centre (DDTC), PGIMER, Chandigarh- Dr. T. Mahintamani In DDTC, PGIMER, a synchronous, stepwise (telephonic, video, and in-person consultation) direct-care model has been adopted for provision of teleconsultation. A psychiatrist with post-graduate qualification performs initial assessment through telephonic or video-consultation. The prescriptions are sent through WhatsApp platform. If there is a felt need for in-person care, the patient is called in the OPD. Whenever required the feedback of consultant is sought after. Patients were found to experience stronger therapeutic relationship and physician empathy with in person consultation. Difficulty in telephonic registration, privacy and connectivity issues were commonly faced by the service users. Dr. Mahintamani will discuss the experience from DDTC, PGI, Chandigarh.
format Online
Article
Text
id pubmed-9129338
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91293382022-05-25 Telemedicine Mediated Service Delivery for Substance Use Disorders Basu, D Indian J Psychiatry Symposium Telemedicine in addiction service delivery- Dr. D Basu For around last two decades, telepsychiatry has been practiced in India to reach the unreached population with variable degree of success. COVID-19 pandemic limited healthcare access due to travel and face to face consultation restrictions. It warranted an urgent and widespread expansion of telepsychiatry practice, and application of the same in management of patients using substance. In spite of the advantage of increased access, there are some inherent limitations in the form of inability to perform detailed physical examination and restriction of medication prescriptions. Dr. Basu will discuss the opportunities and challenges in telemedicine-based service delivery for substance use disorders. Telemedicine and Opioid substitution treatment (OST)- Dr. A. Ghosh Opioid substitution treatment (OST) was significantly affected during pandemic, as there was a strict requirement of face-to-face consultation. Only United States shifted the buprenorphine-naloxone assisted OST induction through teleconsultation. Many other countries including India has allowed preliminary assessment for OST through teleconsultation, but induction and dispensing were essentially through in person consultation. The dispensing of OST has been mechanized in some other countries. Dr. Ghosh will review the adaptations and challenges in OST delivery during the pandemic. Telemedicine mediated service delivery in the Drug Deaddiction & Treatment Centre (DDTC), PGIMER, Chandigarh- Dr. T. Mahintamani In DDTC, PGIMER, a synchronous, stepwise (telephonic, video, and in-person consultation) direct-care model has been adopted for provision of teleconsultation. A psychiatrist with post-graduate qualification performs initial assessment through telephonic or video-consultation. The prescriptions are sent through WhatsApp platform. If there is a felt need for in-person care, the patient is called in the OPD. Whenever required the feedback of consultant is sought after. Patients were found to experience stronger therapeutic relationship and physician empathy with in person consultation. Difficulty in telephonic registration, privacy and connectivity issues were commonly faced by the service users. Dr. Mahintamani will discuss the experience from DDTC, PGI, Chandigarh. Wolters Kluwer - Medknow 2022-03 2022-03-24 /pmc/articles/PMC9129338/ http://dx.doi.org/10.4103/0019-5545.341811 Text en Copyright: © 2022 Indian Journal of Psychiatry https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Symposium
Basu, D
Telemedicine Mediated Service Delivery for Substance Use Disorders
title Telemedicine Mediated Service Delivery for Substance Use Disorders
title_full Telemedicine Mediated Service Delivery for Substance Use Disorders
title_fullStr Telemedicine Mediated Service Delivery for Substance Use Disorders
title_full_unstemmed Telemedicine Mediated Service Delivery for Substance Use Disorders
title_short Telemedicine Mediated Service Delivery for Substance Use Disorders
title_sort telemedicine mediated service delivery for substance use disorders
topic Symposium
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129338/
http://dx.doi.org/10.4103/0019-5545.341811
work_keys_str_mv AT basud telemedicinemediatedservicedeliveryforsubstanceusedisorders